Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SNS-101 |
Trade Name | |
Synonyms | SNS101|SNS 101 |
Drug Descriptions |
SNS-101 is a monoclonal antibody that targets VSIR (VISTA; PD1H), which may lead to increase in tumor-infiltrating T-cells and enhanced antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | VSIR Antibody 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cemiplimab + SNS-101 | Cemiplimab SNS-101 | 0 | 1 |
SNS-101 | SNS-101 | 0 | 1 |